Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA takes steps to foster greater efficiency in biosimilar development by reconsidering draft guidance on evaluating analytical studies

worldpharmanewsJuly 05, 2018

Tag: FDA , foster greater efficiency , evaluating analytical studies

PharmaSources Customer Service